Ignite Creation Date:
2024-05-06 @ 7:34 PM
Last Modification Date:
2024-10-26 @ 3:10 PM
Study NCT ID:
NCT06066216
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-01-23
First Post:
2023-09-27
Brief Title:
Cadonilimab AK104 Plus Chemotherapy in Patients With Recurrent or Advanced Endometrial Cancer
Sponsor:
Fujian Cancer Hospital
Organization:
Fujian Cancer Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-02-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-10-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-10-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-09-27
First Submit QC Date:
September 27 2023
Study First Post Date:
2023-10-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-20
Last Update Post Date:
2024-01-23
Last Update Post Date Type:
ACTUAL